Nothing Special   »   [go: up one dir, main page]

BR112022022263A2 - Tratamento de infecções virais - Google Patents

Tratamento de infecções virais

Info

Publication number
BR112022022263A2
BR112022022263A2 BR112022022263A BR112022022263A BR112022022263A2 BR 112022022263 A2 BR112022022263 A2 BR 112022022263A2 BR 112022022263 A BR112022022263 A BR 112022022263A BR 112022022263 A BR112022022263 A BR 112022022263A BR 112022022263 A2 BR112022022263 A2 BR 112022022263A2
Authority
BR
Brazil
Prior art keywords
treatment
viral infections
infections
viral
invention features
Prior art date
Application number
BR112022022263A
Other languages
English (en)
Inventor
Gojon-Romanillos Gabriel
GOJON-ZORRILLA Gabriel
Original Assignee
Sulfagenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sulfagenix Inc filed Critical Sulfagenix Inc
Publication of BR112022022263A2 publication Critical patent/BR112022022263A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

TRATAMENTO DE INFECÇÕES VIRAIS. A presente invenção apresenta o tratamento de infecções virais, por exemplo, infecções causadas por vírus envelopados, pela administração de composições ricas em enxofre.
BR112022022263A 2020-05-04 2021-05-04 Tratamento de infecções virais BR112022022263A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063019757P 2020-05-04 2020-05-04
PCT/US2021/030591 WO2021226037A1 (en) 2020-05-04 2021-05-04 Treatment of viral infections

Publications (1)

Publication Number Publication Date
BR112022022263A2 true BR112022022263A2 (pt) 2022-12-20

Family

ID=78468308

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022022263A BR112022022263A2 (pt) 2020-05-04 2021-05-04 Tratamento de infecções virais

Country Status (9)

Country Link
US (1) US20230165893A1 (pt)
EP (1) EP4146227A4 (pt)
JP (1) JP2023524269A (pt)
CN (1) CN115484960A (pt)
AU (1) AU2021268622A1 (pt)
BR (1) BR112022022263A2 (pt)
CA (1) CA3177580A1 (pt)
MX (1) MX2022013814A (pt)
WO (1) WO2021226037A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023159060A1 (en) * 2022-02-16 2023-08-24 Prothione Llc Compositions and methods for the treatment of coronavirus diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030235571A1 (en) * 2002-06-19 2003-12-25 Gabriel Gojon-Romanillos Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance
AU2010215880A1 (en) * 2009-02-19 2011-09-15 Bach Pharma, Inc. Methods of treating intestinal diseases and inflammatory conditions related to HIV-AIDS
RU2543319C2 (ru) * 2009-04-10 2015-02-27 КЕТТАНИ Слимен ЭЛЬ Композиция на растительной основе для лечения и профилактики вирусных заболеваний крови, таких заболеваний, как вызванные вирусом иммунодефицита человека (вич) или гепатита с
WO2012092159A1 (en) * 2010-12-31 2012-07-05 Abbott Laboratories Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
US8771755B2 (en) * 2011-09-14 2014-07-08 Nuevas Alternativas Naturales, S.A.P.I. de C.V. Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof
JP6317440B2 (ja) * 2013-10-29 2018-04-25 プレジデント アンド フェローズ オブ ハーバード カレッジ 酸化ストレスを阻害するための方法および組成物
US9694030B2 (en) * 2014-10-17 2017-07-04 Frederick J. Sawaya Composition for treatment, inhibition and attenuation of virus
US20170258827A1 (en) * 2017-05-31 2017-09-14 Frederick J. Sawaya Method for treating cancer

Also Published As

Publication number Publication date
CN115484960A (zh) 2022-12-16
CA3177580A1 (en) 2021-11-11
WO2021226037A8 (en) 2021-12-30
EP4146227A1 (en) 2023-03-15
MX2022013814A (es) 2022-11-30
WO2021226037A1 (en) 2021-11-11
AU2021268622A1 (en) 2022-11-24
EP4146227A4 (en) 2024-01-24
US20230165893A1 (en) 2023-06-01
JP2023524269A (ja) 2023-06-09

Similar Documents

Publication Publication Date Title
BR112018071678A2 (pt) compostos terapêuticos úteis para o tratamento profilático ou terapêutico de uma infecção por vírus hiv
BR112022000503A2 (pt) Compostos úteis para tratar infecções por vírus influenza
BR112019002734A2 (pt) tratamento e remissão virológica sustentada de infecção por hiv por anticorpos para cd4 em pacientes estabilizados por haart
EA201890735A1 (ru) Модуляторы корового белка вируса гепатита b
MX2019009212A (es) Analogos de atazanavir (atv) para tratar infecciones por virus de inmunodeficiencia humana (vih).
PH12020550531A1 (en) Novel, highly active pyrazolo-piperidine substituted indole2-carboxamides active against the hepatitis b virus (hbv)
MX2022015257A (es) Proteinas f de prefusion del virus respiratorio sincicial (vrs) solubles y estabilizadas.
BR112018016842A2 (pt) compostos de piridona tetracíclica como antivirais
BR112019016497A2 (pt) 2-heteroaril-3-oxo-2,3-di-hidropiridazina-4-carboxamidas para o tratamento de câncer.
WO2019086141A8 (en) Novel, highly active amino-thiazole substituted indole-2-carboxamides active against the hepatitis b virus (hbv)
EP4356969A3 (en) Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
EA201891278A1 (ru) Гетероциклические индолы для применения при инфекции, вызванной вирусом гриппа
CY1118399T1 (el) Ενωσεις βενζοφουρανιου για την θεραπεια μολυνσεων ιου ηπατιτιδας c
BR112019006802A2 (pt) compostos e métodos para diagnóstico e tratamento de infecções virais
BR112021021564A2 (pt) Indol-2-carboxamidas inovadoras ativas contra o vírus da hepatite b (hbv)
BR112024000744A2 (pt) Anticorpos de glicoprotéina spike anti-sars-cov-2 e fragmentos de ligação a antígeno
SA520420046B1 (ar) مركبات بيريدازينون ثلاثية الحلقة مندمجة وعقاقير أولية منها مفيدة لعلاج الإصابات الفيروسة المخاطية القويمة
BR112022008183A2 (pt) Formas de sal de um receptor de c5a de componente do complemento
BR112022022263A2 (pt) Tratamento de infecções virais
GB2544439A (en) Antiviral composition
BR112021017525A2 (pt) Formulação sólida de modulador de montagem de capsídeo
BR112015021001A2 (pt) compostos antivirais
ECSP21039816A (es) Anticuerpos monoclonales antirrábicos y cóctel de estos
BR112022001164A2 (pt) Composto, uso de um composto, método para o tratamento ou profilaxia de doenças, composto para uso e composição farmacêutica
MX2021016005A (es) Derivados de aminas terciarias y sus usos para tratar una infección vírica.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]